| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Francesco Lo-Coco | Q69071856 |
| P2093 | author name string | Tamer M Fouad | |
| Safaa M Ramadan | |||
| P2860 | cites work | Global cancer statistics, 2002 | Q27860562 |
| Cancer statistics, 2008 | Q27860585 | ||
| Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7 | Q28307681 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Modern treatments of menorrhagia attributable to dysfunctional uterine bleeding | Q31932763 | ||
| Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results | Q33332312 | ||
| Prevention of menstruation with leuprorelin (GnRH agonist) in women undergoing myelosuppressive chemotherapy or radiochemotherapy for hematological malignancies: a pilot study. | Q33339652 | ||
| Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate | Q33372508 | ||
| Reproductive physiology and treatment-related loss of sex hormone production | Q33684695 | ||
| Topoisomerase II inhibitor-related acute myeloid leukaemia | Q33940241 | ||
| Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: a 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol | Q34083342 | ||
| Cognitive consequences and central nervous system injury following treatment for childhood leukemia | Q34100415 | ||
| Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment | Q34128353 | ||
| Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis | Q34198047 | ||
| Cancer of the ovary | Q34375262 | ||
| Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer | Q34582674 | ||
| Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. | Q34585850 | ||
| Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet | Q34597535 | ||
| Anthracyclines in the treatment of malignancy in pregnancy | Q34686907 | ||
| Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents | Q34688744 | ||
| Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: From the bedside to the target genes | Q35229164 | ||
| Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients | Q35609280 | ||
| Use of chemotherapy during human pregnancy | Q35761685 | ||
| Fertility preservation in female patients | Q35772121 | ||
| Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide | Q36028830 | ||
| Morphological study of the ovaries of leukaemic children | Q36042409 | ||
| Fertility preservation for young patients with cancer: who is at risk and what can be offered? | Q36089802 | ||
| Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. | Q36136829 | ||
| Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years | Q36407114 | ||
| American Society of Clinical Oncology recommendations on fertility preservation in cancer patients | Q36465251 | ||
| Current therapeutic strategies for acute myeloid leukaemia | Q36539598 | ||
| Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. | Q36559394 | ||
| Guidelines on the management of acute myeloid leukaemia in adults | Q36630107 | ||
| Therapy-related myeloid leukemia. | Q37009760 | ||
| Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review | Q37064485 | ||
| Sexual functioning morbidity among cancer survivors. Current status and future research directions | Q37286759 | ||
| Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation | Q37345807 | ||
| Leukemia following breast cancer: an international population-based study of 376,825 women | Q38464538 | ||
| Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy | Q39785729 | ||
| Epidemiology of childhood leukemia, with a focus on infants | Q40504858 | ||
| Growth and endocrine function after bone marrow transplantation | Q40525659 | ||
| Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer | Q40673230 | ||
| Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer | Q41274775 | ||
| Ovarian function after bone marrow transplantation during childhood | Q42451712 | ||
| Gonadal function in patients treated for leukemia in childhood | Q42463896 | ||
| Ovarian function following chemotherapy for childhood brain tumours | Q42497853 | ||
| Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. | Q42511863 | ||
| Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy | Q43614359 | ||
| Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers | Q43671813 | ||
| Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero | Q43846654 | ||
| Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem | Q43863897 | ||
| Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study | Q43882143 | ||
| Pediatric acute lymphoblastic leukemia: redefining outcomes. | Q43980088 | ||
| Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. | Q44054492 | ||
| Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy | Q44080624 | ||
| Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience | Q44117619 | ||
| Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience | Q44381560 | ||
| Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome | Q44399078 | ||
| Therapy-related acute promyelocytic leukemia. | Q44459250 | ||
| Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). | Q44693243 | ||
| Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation. | Q44934791 | ||
| 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop | Q46139148 | ||
| DNA topoisomerase II in therapy-related acute promyelocytic leukemia. | Q46437040 | ||
| Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide | Q46551686 | ||
| Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia | Q47371912 | ||
| Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML | Q47414654 | ||
| Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study | Q48166693 | ||
| Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia. | Q51001401 | ||
| Scholastic achievements of childhood leukemia patients: a nationwide, register-based study. | Q51908420 | ||
| Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences. | Q51950729 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. | Q53316395 | ||
| Leukemia following chemotherapy for ovarian cancer. | Q53405625 | ||
| Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. | Q53455281 | ||
| Cytogenetics of myelodysplasia and acute myeloid leukaemia in aircrew and people treated with radiotherapy | Q58411462 | ||
| P433 | issue | 2 | |
| P921 | main subject | leukemia | Q29496 |
| acute leukemia | Q976388 | ||
| P304 | page(s) | 239-249 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Women's Health | Q15762155 |
| P1476 | title | Acute leukemia in women | |
| P478 | volume | 6 |
| Q33429782 | Effect of silencing HOXA5 gene expression using RNA interference on cell cycle and apoptosis in Jurkat cells | cites work | P2860 |
Search more.